SAFIRA®

Giving Anaesthetists Control

Safer Injection for Regional Anaesthesia

About SAFIRA®

SAFIRA®: SAFer Injection for Regional Anaesthesia

Creates a single operator procedure
Engineered safety solution to control injection pressure threshold
Reduces chances of nerve injury
Improves patient safety

Current Regional Anaesthesia process:

Regional anaesthesia procedures require two operators - an anaesthetist who holds an ultrasound scanner and uses this to guide the needle tip placement and a second operator to inject the anaesthetic solution at a required pressure.

It has been reported that anaesthetic solutions are often injected at high pressure.

High pressure can cause damage to nerve fascicles, with serious nerve damage occurring in up to 1% of procedures and transient nerve damage in up to 8% of cases [1,2].

A revolutionary new technology for Regional Anaesthesia:

SAFIRA® - SAFer Injection for Regional Anaesthesia - allows a single operator, an anaesthetist or anesthesiologist, to conduct the whole regional block at safer pressures.

SAFIRA® has been developed in line with international quality standards. Medovate is ISO 13485:2016 certified.

Contact Distributors:

Medovate have appointed distributors for this exciting new technology.

VYGON is the appointed distributor for Europe and the UK. There are distributors providing 100% coverage in the United States of America. There are also active distributors covering Australia and New Zealand, and Israel.

Find details of all appointed distributors here.

Distributors for other countries are in the process of being appointed.

Videos about SAFIRA®:

Scroll down to find videos about the new SAFIRA® technology for regional anaesthesia.

[References: 1. Borgeat A, Blumenthal S. Nerve injury and regional anaesthesia [Internet]. Vol. 17, Current Opinion in Anaesthesiology. 2004 [cited 2020 Mar 31]. p.417–21. Available from: http://www.ncbi.nlm.nih.gov/pu... 2. Jeng CL, Torrillo TM, Rosenblatt MA. Complications of peripheral nerve blocks. Br J Anaesth [Internet]. 2010 [cited 2020 Mar 31];105(S1):97–107. Available from: https://academic.oup.com/bja/a...]

Request more information

Product Images

SAFIRA® being used with NYSORA simulator

Anaesthetist uses SAFIRA® for an ankle block

Downloads

SAFIRA® Brochure

5 Benefits of SAFIRA®

SAFIRA® Quick Start Guide

SAFIRA® Instructions for Use (IFU)

SAFIRA®: Frequently Asked Questions

Dr Joseph Carter - SAFIRA®: Clinician's View

"During hands on demonstrations of SAFIRA® at events including WAMM 2019, delegates were able to appreciate the ease of use, the engineered safety benefits and the convenience of their ability to retain control as a single operator during the performance of a nerve block."

— Dr Peter Young, Critical Care Consultant, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust

"Having full control over the injection means that I know exactly when, where and how much local anaesthetic I am putting into the patient. And also, the objective pressure limit which is built into the system, provides me with confidence that I am less likely to cause nerve injury."

— Dr Stewart Southey, Consultant Anaesthetist

"SAFIRA® can easily be integrated into clinical practice. The device is very familiar in terms of it being a modified syringe pump. In terms of usage for doing regional anaesthesia blocks, it is very intuitive and it is easy to understand how to aspirate and how to inject using the device."

— Dr Joseph Carter, Consultant Anaesthetist, York Teaching Hospitals NHS Foundation Trust

"My first impressions of SAFIRA® were the simplicity, the ease of use. New clinicians were able to just pick it up and use it straight away without any difficulty at all."

— Mr Chris Withey, Consultant Surgeon (Orthopaedics)

"SAFIRA® will not just make regional anaesthesia more convenient, it will also promote safer regional anaesthesia practice in operating rooms, in the wards and also in emergency departments. I believe SAFIRA® is the biggest development in regional anaesthesia since the introduction of ultrasound."

— Dr. Emad Eldin Fawzy, Consultant Anaesthesia, Shiekh Khalifa Medical City, Abu Dhabi, UAE

Clinical Evidence

Heij R, Eldin E, Young P, Carter J, Gibson J, Ali A, et al. Regional Anesthesiology Injection Pressures...[ABSTRACT]

Borgeat A, Blumenthal S. Nerve injury and regional anaesthesia...[ABSTRACT]

Jeng CL, Torrillo TM, Rosenblatt MA. Complications of peripheral nerve blocks...[ABSTRACT]

Richard Claudio, Admir Hadzic, Henry Shih et al. Injection pressures by anesthesiologists during...[ABSTRACT]

Regional anaesthesia and COVID-19: first choice at last? (Article in British Journal of Anaesthesia, May 2020)

Videos about SAFIRA

Revolutionary new technology for regional anaesthesia

Clinician's View: Dr Joseph Carter, Consultant Anaesthetist & co-inventor of SAFIRA®	SAFIRA® in use to perform an ankle block	A Surgeon's View of SAFIRA®: SAFer Injection for Regional Anaesthesia
Guide to Setting Up & Using SAFIRA	SAFIRA™: An Anesthesiologist's view with Dr Stewart Southey	Why Switch to SAFIRA™? Reason #1 - single person procedure
Why Switch to SAFIRA®? Reason #2 - Gives Anesthesiologists Control	Why Switch to SAFIRA™? Reason #3 - potential to save time and money	Why Switch to SAFIRA™? Reason #4 - prevents injection above 20psi